Emond J, Renier T, Yeum D, Carlson D, Ballarino G, Gilbert-Diamond D
    
    
    Front Psychol. 2025; 15:1395957.
  
  
    PMID: 39845554
    
          PMC: 11752389.
    
          DOI: 10.3389/fpsyg.2024.1395957.
      
 
                                  
  
    Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, Norling B
    
    
    J Addict Psychiatry. 2024; 8(1):50-95.
  
  
    PMID: 39635461
    
          PMC: 11615735.
    
      
 
                                  
  
    Mohammadi M, Omidiani S, Azizbeigi R, Haghparast A
    
    
    Neurochem Res. 2024; 50(1):6.
  
  
    PMID: 39540967
    
    
          DOI: 10.1007/s11064-024-04256-z.
      
 
                                  
  
    Huminska-Lisowska K
    
    
    Int J Mol Sci. 2024; 25(21).
  
  
    PMID: 39519153
    
          PMC: 11546834.
    
          DOI: 10.3390/ijms252111602.
      
 
                                  
  
    Blum K, Elman I, Han D, Hanna C, Baron D, Gupta A
    
    
    Open J Immunol. 2024; 14(3):60-86.
  
  
    PMID: 39507617
    
          PMC: 11539193.
    
          DOI: 10.4236/oji.2024.143006.
      
 
                              
              
                              
                                      
  Working memory gating in obesity is moderated by striatal dopaminergic gene variants.
  
    Herzog N, Hartmann H, Janssen L, Kanyamibwa A, Waltmann M, Kovacs P
    
    
    Elife. 2024; 13.
  
  
    PMID: 39431987
    
          PMC: 11493406.
    
          DOI: 10.7554/eLife.93369.
      
 
                                          
                                                          
  A Complex Relationship Among the Circadian Rhythm, Reward Circuit and Substance Use Disorder (SUD).
  
    Samanta S, Bagchi D, Gold M, Badgaiyan R, Barh D, Blum K
    
    
    Psychol Res Behav Manag. 2024; 17:3485-3501.
  
  
    PMID: 39411118
    
          PMC: 11479634.
    
          DOI: 10.2147/PRBM.S473310.
      
 
                                          
                                                          
  The Influence of Genetic Polymorphic Variability of the Catechol-O-methyltransferase Gene in a Group of Patients with a Diagnosis of Behavioural Addiction, including Personality Traits.
  
    Reclaw R, Chmielowiec K, Suchanecka A, Boron A, Chmielowiec J, Stronska-Pluta A
    
    
    Genes (Basel). 2024; 15(3).
  
  
    PMID: 38540358
    
          PMC: 10969953.
    
          DOI: 10.3390/genes15030299.
      
 
                                          
                                                          
  Are We Getting High Cause the Thrill is Gone?.
  
    Blum K, Mclaughlin T, Gold M, Gondre-Lewis M, Thanos P, Elman I
    
    
    J Addict Psychiatry. 2024; 7(1):5-516.
  
  
    PMID: 38164471
    
          PMC: 10758019.
    
      
 
                                          
                                                          
  Futuristic Exploration of Addiction Neuroscience in the Genomic Era.
  
    Blum K, Elman I, Bowirrat A, Baron D, Thanos P, Hanna C
    
    
    Psychol Res Behav Manag. 2023; 16:4989-4991.
  
  
    PMID: 38094658
    
          PMC: 10717929.
    
          DOI: 10.2147/PRBM.S439837.
      
 
                                          
                                                          
  "TO BE OR NOT TO BE" GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS).
  
    Blum K, Thanos P, Hanna C, Gold M, Baron D, Elman I
    
    
    Psychol Res Behav Manag. 2023; 16:4287-4291.
  
  
    PMID: 37885829
    
          PMC: 10597772.
    
          DOI: 10.2147/PRBM.S428841.
      
 
                                          
                                                          
  The Non-Anhydrous, Minimally Basic Synthesis of the Dopamine D Agonist [18F]MCL-524.
  
    Inkster J, Sromek A, Akurathi V, Neumeyer J, Packard A
    
    
    Chemistry (Basel). 2023; 3(3):1047-1056.
  
  
    PMID: 37830058
    
          PMC: 10569134.
    
          DOI: 10.3390/chemistry3030075.
      
 
                                          
                                                          
  Can We Combat Reward Deficiency Behaviors (RDS) including Substance Use Disorder (SUD) through Genetic Risk Screening coupled with Precision Pro-Dopamine Regulation by Algorithmic matched Polymorphic Allelic Risks.
  
    Blum K, Baron D, Hauser M, Badgaiyan R, Downs B, Siwicki D
    
    
    Madridge J Mol Biol. 2023; 1(1):1-3.
  
  
    PMID: 37736119
    
          PMC: 10512439.
    
      
 
                                          
                                                          
  Evidence for the  Gene as a Determinant of Reward Deficiency Syndrome (RDS).
  
    Blum K, Bowirrat A, Elman I, Baron D, Thanos P, Gold M
    
    
    Clin Exp Psychol. 2023; 9(4):8-11.
  
  
    PMID: 37560184
    
          PMC: 10411139.
    
      
 
                                          
                                                          
  Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: a systematic review and meta-analysis.
  
    Ribeiro G, Maia A, Cotovio G, Oliveira F, Costa D, Oliveira-Maia A
    
    
    Sci Rep. 2023; 13(1):4959.
  
  
    PMID: 36973321
    
          PMC: 10042861.
    
          DOI: 10.1038/s41598-023-31250-2.
      
 
                                          
                                                          
  Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family.
  
    Dennen C, Blum K, Bowirrat A, Thanos P, Elman I, Ceccanti M
    
    
    J Pers Med. 2022; 12(11).
  
  
    PMID: 36579592
    
          PMC: 9694640.
    
          DOI: 10.3390/jpm12111864.
      
 
                                          
                                                          
  Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index.
  
    Blum K, Han D, Bowirrat A, Downs B, Bagchi D, Thanos P
    
    
    J Pers Med. 2022; 12(11).
  
  
    PMID: 36579510
    
          PMC: 9696872.
    
          DOI: 10.3390/jpm12111772.
      
 
                                          
                                                          
  Hypothesizing That Pediatric Autoimmune Neuropsychiatric Associated Streptococcal (PANDAS) Causes Rapid Onset of Reward Deficiency Syndrome (RDS) Behaviors and May Require Induction of "Dopamine Homeostasis".
  
    Blum K, Dennen C, Braverman E, Gupta A, Baron D, Downs B
    
    
    Open J Immunol. 2022; 12(3):65-75.
  
  
    PMID: 36407790
    
          PMC: 9670240.
    
          DOI: 10.4236/oji.2022.123004.
      
 
                                          
                                                          
  Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?.
  
    Blum K, Dennen C, Elman I, Bowirrat A, Thanos P, Badgaiyan R
    
    
    J Pers Med. 2022; 12(10).
  
  
    PMID: 36294858
    
          PMC: 9604605.
    
          DOI: 10.3390/jpm12101719.
      
 
                                          
                                                          
  DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave and Other Neurobiologically Based Modalities to Address Complexities of Chronic Pain in a Female Diagnosed with Reward Deficiency Syndrome (RDS): Emergence of Induction of....
  
    Bajaj A, Blum K, Bowirrat A, Gupta A, Baron D, Fugel D
    
    
    J Pers Med. 2022; 12(9).
  
  
    PMID: 36143203
    
          PMC: 9503998.
    
          DOI: 10.3390/jpm12091416.